Stratec Stock

Stratec ROCE 2024

Stratec ROCE

0.11

Ticker

SBS.DE

ISIN

DE000STRA555

WKN

STRA55

In 2024, Stratec's return on capital employed (ROCE) was 0.11, a -41.95% increase from the 0.19 ROCE in the previous year.

Stratec Aktienanalyse

What does Stratec do?

The company Stratec SE is a German company operating in the medical technology industry. It was founded in 1984 and has since become a leading provider of automation solutions and diagnostic instruments. Stratec's business model is based on the development and production of devices and systems used in medical diagnostics. The company focuses in particular on the areas of immunology, clinical chemistry, and hematology. Stratec also offers innovative solutions in microscopy and cell analysis. In the "automation solutions" division, Stratec develops systems for the automation of laboratory processes. These are mainly used in clinical diagnostics to accelerate and simplify workflow. Examples include sample identification systems, pipetting robots, and analysis devices. In the "in vitro diagnostics" division, Stratec offers products for determining blood values. This includes devices for determining glucose, cholesterol, and hemoglobin levels, as well as devices for infection diagnostics and tumor and allergy diagnostics. Another division of Stratec is "microscopy." The company manufactures automated microscope systems, primarily used in biomedical research to analyze cells and tissues. In the "cell analysis" division, Stratec offers innovative methods for analyzing cells, such as cell growth and vitality determination. Stratec always focuses on tailoring the design of its products to the needs of its customers. High flexibility in device development and manufacturing is therefore an important factor in the company's success. In addition to device development and production, Stratec also provides services related to its products. These include installation, maintenance, and on-site repair of devices for customers. Stratec SE operates internationally and has branches in Europe, Asia, and America. The company employs over 1,000 people worldwide. Overall, Stratec SE is a successful and renowned provider of medical devices and systems for automating laboratory processes. With its diverse product portfolio and high flexibility in customer support, Stratec has earned a leading position in the industry. Stratec ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Stratec's Return on Capital Employed (ROCE)

Stratec's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Stratec's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Stratec's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Stratec’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Stratec stock

What is the ROCE (Return on Capital Employed) of Stratec this year?

The ROCE of Stratec is 0.11 undefined this year.

How has the ROCE (Return on Capital Employed) of Stratec developed compared to the previous year?

The ROCE of Stratec has increased by -41.95% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Stratec?

A high Return on Capital Employed (ROCE) indicates that Stratec has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Stratec?

A low ROCE (Return on Capital Employed) can indicate that Stratec has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Stratec impact the company?

An increase in the ROCE of Stratec can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Stratec affect the company?

A decrease in ROCE of Stratec can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Stratec?

Some factors that can affect Stratec's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Stratec so important for investors?

The ROCE of Stratec is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Stratec take to improve the ROCE?

To improve the ROCE, Stratec can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Stratec pay?

Over the past 12 months, Stratec paid a dividend of 0.97 EUR . This corresponds to a dividend yield of about 2.52 %. For the coming 12 months, Stratec is expected to pay a dividend of 1.05 EUR.

What is the dividend yield of Stratec?

The current dividend yield of Stratec is 2.52 %.

When does Stratec pay dividends?

Stratec pays a quarterly dividend. This is distributed in the months of June, June, June, June.

How secure is the dividend of Stratec?

Stratec paid dividends every year for the past 0 years.

What is the dividend of Stratec?

For the upcoming 12 months, dividends amounting to 1.05 EUR are expected. This corresponds to a dividend yield of 2.73 %.

In which sector is Stratec located?

Stratec is assigned to the 'Health' sector.

Wann musste ich die Aktien von Stratec kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Stratec from 5/22/2024 amounting to 0.55 EUR, you needed to have the stock in your portfolio before the ex-date on 5/20/2024.

When did Stratec pay the last dividend?

The last dividend was paid out on 5/22/2024.

What was the dividend of Stratec in the year 2023?

In the year 2023, Stratec distributed 0.95 EUR as dividends.

In which currency does Stratec pay out the dividend?

The dividends of Stratec are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Stratec stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Stratec

Our stock analysis for Stratec Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stratec Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.